Menu Close Call 1-800-CEDARS-1 toggle search form Close
COVID-19 (Coronavirus)
Information for Patients & Visitors

Mazen Noureddin, MD

Director, Cedars-Sinai Fatty Liver Program

Mazen Noureddin, MD

Liver Disease & Transplant Center
8900 Beverly Blvd - 3rd Floor
Los Angeles, CA
90048

Phone:

310-423-6000

Fax:

310-423-2356

Mazen Noureddin, MD

Director, Cedars-Sinai Fatty Liver Program

  • IM/Gastroenterology
  • Fatty Liver Disease
  • Hepatology
  • Liver Transplant

Fatty Liver Disease [Alcoholic (ALD), Nonalcoholic (NAFLD), Pregnancy]

Hepatitis (A, B, C)

Liver Cancers

Liver Disorders

Liver Failure

Liver Transplants

Upper Gastrointestinal Endoscopy

The research of Mazen Noureddin, MD, focuses on the underlying mechanisms of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), new imaging modalities and exploring new treatments. He has conducted several original studies that have been featured in publications such as Gastroenterology, Hepatology and The American Journal of Gastroenterology, among many others. The Fatty Liver Program at Cedars-Sinai has many breakthrough clinical trials targeting new therapies in patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitisn (NASH), including those with advanced fibrosis and cirrhosis.

  • Residency: University of Southern California, 2005
  • Fellowship: National Institutes of Health, 2008
  • Master's: Duke University School of Medicine, 2009
  • Fellowship: University of California, San Diego School of Medicine, 2011
  • American Liver Foundation (ALF): Health Care Visionary Award, 2016
  • Clinical Scholar Program, Cedars Sinai, 2015
  • Top Doctors, Pasadena Magazine, 2014, 2015
  • AGA-AASLD Academic Skill Workshop. San Diego CA (invited), 2013
  • 2nd Award of Research Poster Competition in San Diego Gastroenterology Society, 2012

Click here for a list of peer-reviewed publications.

  • Noureddin M, Khoyliar C, Palmer SL. MRI, CT scan and ultrasound in the diagnosis of nonalcoholic fatty liver disease. J Clin Gastroenterol. 2015;49(4):351-352.
  • Noureddin M, Mato JM, Lu SC. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. Exp Biol Med (Maywood). 2015;240(6):809-820.
  • Noureddin M, Rinella ME. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma. Clin Liver Dis. 2015;19(2):361-379.

English / Arabic

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.